Literature DB >> 20385796

Modeling familial Danish dementia in mice supports the concept of the amyloid hypothesis of Alzheimer's disease.

Janaky Coomaraswamy1, Ellen Kilger, Heidrun Wölfing, Claudia Schäfer, Stephan A Kaeser, Bettina M Wegenast-Braun, Jasmin K Hefendehl, Hartwig Wolburg, Matthew Mazzella, Jorge Ghiso, Michel Goedert, Haruhiko Akiyama, Francisco Garcia-Sierra, David P Wolfer, Paul M Mathews, Mathias Jucker.   

Abstract

Familial Danish dementia (FDD) is a progressive neurodegenerative disease with cerebral deposition of Dan-amyloid (ADan), neuroinflammation, and neurofibrillary tangles, hallmark characteristics remarkably similar to those in Alzheimer's disease (AD). We have generated transgenic (tg) mouse models of familial Danish dementia that exhibit the age-dependent deposition of ADan throughout the brain with associated amyloid angiopathy, microhemorrhage, neuritic dystrophy, and neuroinflammation. Tg mice are impaired in the Morris water maze and exhibit increased anxiety in the open field. When crossed with TauP301S tg mice, ADan accumulation promotes neurofibrillary lesions, in all aspects similar to the Tau lesions observed in crosses between beta-amyloid (Abeta)-depositing tg mice and TauP301S tg mice. Although these observations argue for shared mechanisms of downstream pathophysiology for the sequence-unrelated ADan and Abeta peptides, the lack of codeposition of the two peptides in crosses between ADan- and Abeta-depositing mice points also to distinguishing properties of the peptides. Our results support the concept of the amyloid hypothesis for AD and related dementias, and suggest that different proteins prone to amyloid formation can drive strikingly similar pathogenic pathways in the brain.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20385796      PMCID: PMC2867864          DOI: 10.1073/pnas.1001056107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease.

Authors:  Gorazd B Stokin; Concepción Lillo; Tomás L Falzone; Richard G Brusch; Edward Rockenstein; Stephanie L Mount; Rema Raman; Peter Davies; Eliezer Masliah; David S Williams; Lawrence S B Goldstein
Journal:  Science       Date:  2005-02-25       Impact factor: 47.728

Review 2.  Chromosome 13 dementias.

Authors:  A Rostagno; Y Tomidokoro; T Lashley; D Ng; G Plant; J Holton; B Frangione; T Revesz; J Ghiso
Journal:  Cell Mol Life Sci       Date:  2005-08       Impact factor: 9.261

3.  Genetic modification of the phenotypes produced by amyloid precursor protein overexpression in transgenic mice.

Authors:  G A Carlson; D R Borchelt; A Dake; S Turner; V Danielson; J D Coffin; C Eckman; J Meiners; S P Nilsen; S G Younkin; K K Hsiao
Journal:  Hum Mol Genet       Date:  1997-10       Impact factor: 6.150

4.  Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology.

Authors:  C Sturchler-Pierrat; D Abramowski; M Duke; K H Wiederhold; C Mistl; S Rothacher; B Ledermann; K Bürki; P Frey; P A Paganetti; C Waridel; M E Calhoun; M Jucker; A Probst; M Staufenbiel; B Sommer
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

5.  Familial Danish dementia: co-existence of Danish and Alzheimer amyloid subunits (ADan AND A{beta}) in the absence of compact plaques.

Authors:  Yasushi Tomidokoro; Tammaryn Lashley; Agueda Rostagno; Thomas A Neubert; Marie Bojsen-Møller; Hans Braendgaard; Gordon Plant; Janice Holton; Blas Frangione; Tamas Révész; Jorge Ghiso
Journal:  J Biol Chem       Date:  2005-08-09       Impact factor: 5.157

6.  Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology.

Authors:  Rebecca Radde; Tristan Bolmont; Stephan A Kaeser; Janaky Coomaraswamy; Dennis Lindau; Lars Stoltze; Michael E Calhoun; Fabienne Jäggi; Hartwig Wolburg; Simon Gengler; Christian Haass; Bernardino Ghetti; Christian Czech; Christian Hölscher; Paul M Mathews; Mathias Jucker
Journal:  EMBO Rep       Date:  2006-08-11       Impact factor: 8.807

7.  Furin mediates enhanced production of fibrillogenic ABri peptides in familial British dementia.

Authors:  S H Kim; R Wang; D J Gordon; J Bass; D F Steiner; D G Lynn; G Thinakaran; S C Meredith; S S Sisodia
Journal:  Nat Neurosci       Date:  1999-11       Impact factor: 24.884

8.  BRI2 interacts with amyloid precursor protein (APP) and regulates amyloid beta (Abeta) production.

Authors:  Angeliki Fotinopoulou; Maria Tsachaki; Maria Vlavaki; Alexandros Poulopoulos; Agueda Rostagno; Blas Frangione; Jorge Ghiso; Spiros Efthimiopoulos
Journal:  J Biol Chem       Date:  2005-07-18       Impact factor: 5.157

9.  The familial dementia BRI2 gene binds the Alzheimer gene amyloid-beta precursor protein and inhibits amyloid-beta production.

Authors:  Shuji Matsuda; Luca Giliberto; Yukiko Matsuda; Peter Davies; Eileen McGowan; Fiona Pickford; Jorge Ghiso; Blas Frangione; Luciano D'Adamio
Journal:  J Biol Chem       Date:  2005-06-27       Impact factor: 5.157

Review 10.  Modeling familial British dementia in transgenic mice.

Authors:  Fiona Pickford; Janaky Coomaraswamy; Mathias Jucker; Eileen McGowan
Journal:  Brain Pathol       Date:  2006-01       Impact factor: 6.508

View more
  28 in total

1.  Danish dementia mice suggest that loss of function and not the amyloid cascade causes synaptic plasticity and memory deficits.

Authors:  Robert Tamayev; Shuji Matsuda; Mauro Fà; Ottavio Arancio; Luciano D'Adamio
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-22       Impact factor: 11.205

2.  Memory deficits due to familial British dementia BRI2 mutation are caused by loss of BRI2 function rather than amyloidosis.

Authors:  Robert Tamayev; Luca Giliberto; Wei Li; Cristina d'Abramo; Ottavio Arancio; Ruben Vidal; Luciano D'Adamio
Journal:  J Neurosci       Date:  2010-11-03       Impact factor: 6.167

3.  The benefits and limitations of animal models for translational research in neurodegenerative diseases.

Authors:  Mathias Jucker
Journal:  Nat Med       Date:  2010-09-21       Impact factor: 53.440

4.  Medin aggregation causes cerebrovascular dysfunction in aging wild-type mice.

Authors:  Karoline Degenhardt; Jessica Wagner; Angelos Skodras; Michael Candlish; Anna Julia Koppelmann; Katleen Wild; Rusheka Maxwell; Carola Rotermund; Felix von Zweydorf; Christian Johannes Gloeckner; Hannah A Davies; Jillian Madine; Domenico Del Turco; Regina Feederle; Tammaryn Lashley; Thomas Deller; Philipp Kahle; Jasmin K Hefendehl; Mathias Jucker; Jonas J Neher
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-08       Impact factor: 11.205

Review 5.  Amyloid-β and tau--a toxic pas de deux in Alzheimer's disease.

Authors:  Lars M Ittner; Jürgen Götz
Journal:  Nat Rev Neurosci       Date:  2010-12-31       Impact factor: 34.870

6.  BRI2 protein regulates β-amyloid degradation by increasing levels of secreted insulin-degrading enzyme (IDE).

Authors:  Ellen Kilger; Anika Buehler; Heidrun Woelfing; Sathish Kumar; Stephan A Kaeser; Amudha Nagarathinam; Jochen Walter; Mathias Jucker; Janaky Coomaraswamy
Journal:  J Biol Chem       Date:  2011-08-26       Impact factor: 5.157

Review 7.  Aberrant protein structure and diseases of the brain.

Authors:  A T Welzel; D M Walsh
Journal:  Ir J Med Sci       Date:  2010-10-20       Impact factor: 1.568

8.  Increased AβPP processing in familial Danish dementia patients.

Authors:  Shuji Matsuda; Robert Tamayev; Luciano D'Adamio
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

9.  APP heterozygosity averts memory deficit in knockin mice expressing the Danish dementia BRI2 mutant.

Authors:  Robert Tamayev; Shuji Matsuda; Luca Giliberto; Ottavio Arancio; Luciano D'Adamio
Journal:  EMBO J       Date:  2011-05-17       Impact factor: 11.598

10.  Brain homogenates from human tauopathies induce tau inclusions in mouse brain.

Authors:  Florence Clavaguera; Hiroyasu Akatsu; Graham Fraser; R Anthony Crowther; Stephan Frank; Jürgen Hench; Alphonse Probst; David T Winkler; Julia Reichwald; Matthias Staufenbiel; Bernardino Ghetti; Michel Goedert; Markus Tolnay
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.